Apexigen, Inc. Proceeds from Common Stock Issued
Apexigen, Inc. reported Proceeds from Common Stock Issued of $2.50 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2023-02-22
- Apexigen, Inc. proceeds from issuance of common stock for the quarter ending 2022-12-31 was $0.00.
- Apexigen, Inc. proceeds from issuance of common stock for the quarter ending 2021-12-31 was $0.00.
- Apexigen, Inc. proceeds from issuance of common stock for fiscal 2022 was $2.50M.
- Apexigen, Inc. proceeds from issuance of common stock for fiscal 2021 was $0.00.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 4 month | Proceeds from Issuance of Common Stock 7 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $2.50M 10-K · filed 2023-02-22 | |||
| 2022-09-30 | $2.50M 10-Q · filed 2022-11-14 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $0.00 10-K · filed 2023-02-22 | |||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | ||||
| 2020-12-31 | $978.00 10-K · filed 2022-04-07 | ||||
| 2020-09-30 | $978.00 10-Q · filed 2021-12-09 |